Annual Total Long Term Liabilities
$0.00
-$2.82 M-100.00%
December 31, 2023
Summary
- As of March 6, 2025, NRXP annual total long term liabilities is $0.00, with the most recent change of -$2.82 million (-100.00%) on December 31, 2023.
- During the last 3 years, NRXP annual total long term liabilities has fallen by -$548.00 thousand (-100.00%).
- NRXP annual total long term liabilities is now -100.00% below its all-time high of $2.82 million, reached on December 31, 2022.
Performance
NRXP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.98 M
+$2.98 M+100.00%
September 30, 2024
Summary
- As of March 6, 2025, NRXP quarterly total long term liabilities is $2.98 million, with the most recent change of +$2.98 million (+100.00%) on September 30, 2024.
- Over the past year, NRXP quarterly long term liabilities has increased by +$2.98 million (+100.00%).
- NRXP quarterly long term liabilities is now at all-time high.
Performance
NRXP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NRXP Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +100.0% |
| 3 y3 years | -100.0% | +100.0% |
| 5 y5 years | -100.0% | - |
NRXP Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | at high | -100.0% |
| 5 y | 5-year | -100.0% | at low | at high | -100.0% |
| alltime | all time | -100.0% | at low | at high | -100.0% |
NRx Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.98 M(>+9900.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $2.82 M(>+9900.0%) | $2.82 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $512.50 K(-6.5%) |
| Dec 2020 | $548.00 K | $548.00 K |
FAQ
- What is NRx Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual total long term liabilities year-on-year change?
- What is NRx Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly long term liabilities year-on-year change?
What is NRx Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of NRXP is $0.00
What is the all time high annual total long term liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total long term liabilities is $2.82 M
What is NRx Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, NRXP annual total long term liabilities has changed by -$2.82 M (-100.00%)
What is NRx Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of NRXP is $2.98 M
What is the all time high quarterly long term liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total long term liabilities is $2.98 M
What is NRx Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, NRXP quarterly total long term liabilities has changed by +$2.98 M (+100.00%)